How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

The ABCs of the CBC - Overview and Practical Insights on RBC Paramet…

The Blood Project

W. Aird

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Experts Discuss Pros and Cons of Treatment Approaches in PV

BMFcases

T. Bat, A. Tefferi

2024 Updates in PV/ET

University of Colorado Division of Hematology

B. McMahon

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

Diagnosis and Prognosis in PV: Utility of BM Biopsy, Clinical Findin…

BMFcases

T. Bat, A. Tefferi

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

Marc Zumberg

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Hematologic Emergencies - Bleeding to Clotting

Medical College of Georgia - Augusta University

G. Raval

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Exercises in CBC Interpretation - Focus on WBCs and Platelets

The Blood Project

W. Aird

State-of-the-Art in ITP: Updates and Remaining Challenges

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. Provan